Results 11 to 20 of about 2,645,583 (208)
Past, present, and future of hormonal therapy in recurrent endometrial cancer
Matthew J Carlson, Kristina W Thiel, Kimberly K LeslieDepartment of Obstetrics and Gynecology, University of Iowa, Iowa City, IA, USAAbstract: Endometrial cancer is a heterogeneous disease.
Carlson MJ, Thiel KW, Leslie KK
doaj +1 more source
Profiling and hormonal therapy for acne in women
Acne vulgaris is the most common condition treated by physicians worldwide. Though most acne patients remit spontaneously, for the ones that do not or are unresponsive to conventional therapy or have obvious cutaneous signs of hyperandrogenism, hormonal ...
Sangita Ghosh +3 more
doaj +2 more sources
Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer [PDF]
BACKGROUND: Approximately 20% of women with endometrial cancer have advanced-stage disease or suffer from a recurrence. For these women, prognosis is poor, and palliative treatment options include hormonal therapy and chemotherapy.
Inda, M.A. +32 more
core +1 more source
Bioidentical Hormone Therapy [PDF]
The change in hormonal milieu associated with perimenopause and menopause can lead to a variety of symptoms that can affect a woman's quality of life. Postmenopausal hormone therapy (HT) is an effective, well-tolerated treatment for these symptoms. However, combined HT consisting of conjugated equine estrogen and medroxyprogesterone acetate has been ...
Julia A, Files +2 more
openaire +2 more sources
Hormonal therapy has long been a treatment modality for recurrent endometrial cancer. It is appealing for patients with low-grade, slow-growing tumors or in patients for which other treatment types may be too toxic. Hormonal therapy is well tolerated and
Vincent M. Wagner, Floor J. Backes
core +1 more source
Optimizing Outcomes in Breast Reconstruction: The Role of Hormonal Therapy Management. [PDF]
Background: Breast cancer comprises diverse subtypes with prognostic and therapeutic implications. Hormone therapy plays a crucial role in managing tumors expressing hormonal receptors, but its impact on breast reconstruction outcomes remains unclear ...
Saorín-Gascón E +8 more
europepmc +2 more sources
Lapatinib in the Treatment of Hormone Receptor-Positive/ErbB2-Positive Breast Cancer [PDF]
In women with estrogen receptor(ER)- and ErbB2(HER2)-positive breast cancer, a vicious cycle is established between ER mechanisms of action and the growth factor receptor network, leading to enhanced cell proliferation and endocrine resistance.
Bauerfeind, Ingo +2 more
core +1 more source
The seventieth anniversary of the hormonal treatment of prostatic carcinoma [PDF]
Hormonal treatment of prostatic carcinoma was initiated in the first half of twentieth century. Theoretical basis of hormonal treatment was established with the work of Charles Brenton Huggins published in 1941.
Milovanović Lela
doaj +1 more source
Liver Microenvironment Response to Prostate Cancer Metastasis and Hormonal Therapy
Prostate cancer-associated deaths arise from disease progression and metastasis. Metastasis to the liver is associated with the worst clinical outcomes for prostate cancer patients, and these metastatic tumors can be particularly resistant to the ...
Charlotte L. Bevan +7 more
core +1 more source
This article aims at identifying different preferences for gender roles in transgender persons and the associations of those preferences with well-being at the different stages of medical transition. A total of 148 Russian transgender subjects (64 in pre-
Sergey Kumchenko +3 more
doaj +1 more source

